SCHEMBL12503

SCHEMBL12503

Cc1cc(O)cc(Cl)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30413015 1.00
SCHEMBL11574035 0.78 ALDH1A1 (1.00)
SCHEMBL330662 0.78
SCHEMBL69832 0.78
SCHEMBL147796 0.78
SCHEMBL28714 0.78
Orcinol SCHEMBL68497 0.78
SCHEMBL170788 0.78
Water SCHEMBL16553164 0.76 TSHR (0.57)
SCHEMBL29478143 0.76 TSHR (0.57)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 249 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122037020-A Supported catalyst, preparation method thereof and application thereof in olefin polymerization 中国石油化工股份有限公司 2026-05-15 CN claimed
EP-4419532-A1 FUSED BICYCLIC HETEROARYL COMPOUNDS USEFUL AS NLRP3 INHIBITORS F. Hoffmann-La Roche AG (CH) 2024-08-28 EP claimed
US-20240279237-A1 FUSED BICYCLIC HETEROARYL COMPOUNDS USEFUL AS NLRP3 INHIBITORS HOFFMANN-LA ROCHE INC. (US) 2024-08-22 US claimed
WO-2023066825-A1 FUSED BICYCLIC HETEROARYL COMPOUNDS USEFUL AS NLRP3 INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2023-04-27 WO claimed
CN-113583240-A PI developing solution for flexible panel 江阴润玛电子材料股份有限公司 2021-11-02 CN claimed
EP-3134391-A1 DIAMINOTRIAZINE COMPOUNDS AND THEIR USE AS HERBICIDES BASF SE (DE) 2017-03-01 EP claimed
WO-2015162166-A1 DIAMINOTRIAZINE COMPOUNDS AND THEIR USE AS HERBICIDES BASF SE (DE) 2015-10-29 WO claimed
US-5235022-A Radiation sensitive; positive-working photoresists OCG MICROELECTRONIC MATERIALS, INC. (US) 1993-08-10 US claimed
US-5234795-A Blocked novolak copolymer OCG MICROELECTRONIC MATERIALS, INC. (US) 1993-08-10 US claimed
US-5188921-A Mixture of o-quinonediazide compound and phenolic resin OCG MICROELECTRONIC MATERIALS, INC. (US) 1993-02-23 US claimed
EP-0299890-B1 PROCESS FOR THE CHLORINATION OF PHENOLIC COMPOUNDS RHONE-POULENC CHIMIE (FR) 1991-12-11 EP claimed
EP-0283411-B1 PROCESS FOR CHLORINATING PHENOLIC COMPOUNDS RHONE-POULENC CHIMIE (FR) 1991-08-07 EP claimed
EP-0255452-B1 PROCESS FOR CHLORINATING PHENOLIC COMPOUNDS RHONE-POULENC CHIMIE (FR) 1990-01-24 EP claimed
EP-0299890-A1 Process for the chlorination of phenolic compounds RHONE-POULENC CHIMIE (FR) 1989-01-18 EP claimed
EP-0283411-A1 Process for chlorinating phenolic compounds RHONE-POULENC CHIMIE (FR) 1988-09-21 EP claimed
EP-0255452-A1 Process for chlorinating phenolic compounds RHONE-POULENC CHIMIE (FR) 1988-02-03 EP claimed
EP-0023406-B1 PROCESS FOR PREPARING AROMATIC POLYIMIDE SEMIPERMEABLE MEMBRANES UBE INDUSTRIES, LTD. (JP) 1983-04-13 EP claimed
US-4378324-A DISSOLVING IN A PHENOL, COAGULATING WITH AN ALIPHATIC ALCOHOL, ALIPHATIC KETONE, ETHER, AMIDE, OR DIMETHYL SULFOXIDE UBE INDUSTRIES, LTD. (JP) 1983-03-29 US claimed
EP-0023406-A1 Process for preparing aromatic polyimide semipermeable membranes UBE INDUSTRIES, LTD. (JP) 1981-02-04 EP claimed
CN-122037020-A Supported catalyst, preparation method thereof and application thereof in olefin polymerization 中国石油化工股份有限公司 2026-05-15 CN disclosed
EP-4680601-A1 PYRIDAZINE COMPOUNDS, THEIR PREPARATION, AND THEIR THERAPEUTIC USES Sanofi (FR) 2026-01-21 EP disclosed
EP-4656635-A1 SUBSTITUTED BENZENE COMPOUND Daiichi Sankyo Company, Limited (JP) 2025-12-03 EP disclosed
US-12466781-B2 Thyromimetics AUTOBAHN THERAPEUTICS, INC. (US) 2025-11-11 US disclosed
US-12398136-B2 Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 inhibitors VENTUS THERAPEUTICS U.S., INC. (US) 2025-08-26 US disclosed
US-12331048-B2 Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 inhibitors VENTUS THERAPEUTICS U.S., INC. (US) 2025-06-17 US disclosed
US-12312351-B2 Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 inhibitors VENTUS THERAPEUTICS U.S., INC. (US) 2025-05-27 US disclosed
EP-4499638-A1 PYRIDO-[3,4-D]PYRIDAZINE AMINE DERIVATIVES USEFUL AS NLRP3 DERIVATIVES Ventus Therapeutics U.S., Inc. (US) 2025-02-05 EP disclosed
US-20240409540-A1 PYRIDO-[3,4-d]PYRIDAZINE AMINE DERIVATIVES USEFUL AS NLRP3 INHIBITORS VENTUS THERAPEUTICS U S INC (US) 2024-12-12 US disclosed
US-20240383896-A1 PYRIDO-[3,4-d]PYRIDAZINE AMINE DERIVATIVES USEFUL AS NLRP3 INHIBITORS VENTUS THERAPEUTICS U.S., INC. 2024-11-21 US disclosed
US-20240360130-A1 PYRIDO-[3,4-d]PYRIDAZINE AMINE DERIVATIVES USEFUL AS NLRP3 INHIBITORS VENTUS THERAPEUTICS U.S., INC. 2024-10-31 US disclosed
US-20240360151-A1 PYRIDAZINE COMPOUNDS, THEIR PREPARATION, AND THEIR THERAPEUTIC USES SANOFI (FR) 2024-10-31 US disclosed
WO-2024188994-A1 PYRIDAZINE COMPOUNDS, THEIR PREPARATION, AND THEIR THERAPEUTIC USES SANOFI (FR) 2024-09-19 WO disclosed
EP-4419532-A1 FUSED BICYCLIC HETEROARYL COMPOUNDS USEFUL AS NLRP3 INHIBITORS F. Hoffmann-La Roche AG (CH) 2024-08-28 EP disclosed
US-20240279237-A1 FUSED BICYCLIC HETEROARYL COMPOUNDS USEFUL AS NLRP3 INHIBITORS HOFFMANN-LA ROCHE INC. (US) 2024-08-22 US disclosed
WO-2024157953-A1 SUBSTITUTED BENZENE COMPOUND 第一三共株式会社 2024-08-02 WO disclosed
US-20240174661-A1 PYRIDO-[3,4-d]PYRIDAZINE AMINE DERIVATIVES USEFUL AS NLRP3 INHIBITORS VENTUS THERAPEUTICS U.S., INC. 2024-05-30 US disclosed
CN-112679635-B Preparation method of supported metallocene catalyst and catalyst prepared by preparation method 中国石油化工股份有限公司 2024-03-26 CN disclosed
US-20240009169-A9 PPARG Modulators for the Treatment of Osteoporosis UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED 2024-01-11 US disclosed
US-11858907-B2 Kinase modulators RHIZEN PHARMACEUTICALS AG (CH) 2024-01-02 US disclosed
US-11827596-B2 Thyromimetics AUTOBAHN THERAPEUTICS, INC. (US) 2023-11-28 US disclosed
WO-2023183943-A1 PYRIDO-[3,4-D]PYRIDAZINE AMINE DERIVATIVES USEFUL AS NLRP3 DERIVATIVES VENTUS THERAPEUTICS U.S., INC. (US) 2023-09-28 WO disclosed
US-20230242471-A1 THYROMIMETICS AUTOBAHN THERAPEUTICS, INC. 2023-08-03 US disclosed
US-20230242471-A1 THYROMIMETICS AUTOBAHN THERAPEUTICS, INC. 2023-08-03 US disclosed
US-11667606-B2 Thyromimetics AUTOBAHN THERAPEUTICS, INC. (US) 2023-06-06 US disclosed
WO-2023073115-A1 PROTEIN AGGREGATION INHIBITING COMPOUNDS FOR PLANT DISEASE CONTROL MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2023-05-04 WO disclosed
WO-2023066825-A1 FUSED BICYCLIC HETEROARYL COMPOUNDS USEFUL AS NLRP3 INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2023-04-27 WO disclosed
US-20230072933-A1 PPARG Modulators for the Treatment of Osteoporosis SCRIPPS RESEARCH INST (US) 2023-03-09 US disclosed
US-20230048992-A1 NOVEL THYROMIMETICS AUTOBAHN THERAPEUTICS, INC. 2023-02-16 US disclosed
WO-2022262686-A1 KRAS G12D INHIBITORS JINGRUI BIOPHARMA CO., LTD. (CN) 2022-12-22 WO disclosed
CN-115279359-A Novel thyromimetic agents 速通医疗公司 2022-11-01 CN disclosed
EP-4065098-A1 NOVEL THYROMIMETICS Autobahn Therapeutics, Inc. (US) 2022-10-05 EP disclosed
CN-109790149-B Phenoxytriazoles 豪夫迈·罗氏有限公司 2022-05-17 CN disclosed
US-11319314-B2 Phenoxytriazoles HOFFMANN-LA ROCHE INC. (US) 2022-05-03 US disclosed
CN-109956858-B Method for preparing 3-methoxy-4-hydroxymandelic acid 万华化学集团股份有限公司 2022-02-15 CN disclosed
EP-3931180-A1 NOVEL THYROMIMETICS Autobahn Therapeutics, Inc. (US) 2022-01-05 EP disclosed
WO-2021257851-A1 THYROMIMETICS AUTOBAHN THERAPEUTICS, INC. (US) 2021-12-23 WO disclosed
CN-113784950-A Novel thyromimetic agents 速通医疗公司 2021-12-10 CN disclosed
CN-113583240-A PI developing solution for flexible panel 江阴润玛电子材料股份有限公司 2021-11-02 CN disclosed
EP-3894383-A1 NOVEL THYROMIMETICS Autobahn Therapeutics, Inc. (US) 2021-10-20 EP disclosed
US-20210309653-A1 PHENOXYTRIAZOLES HOFFMANN-LA ROCHE INC. (US) 2021-10-07 US disclosed
CN-113423684-A Novel thyromimetic agents 速通医疗公司 2021-09-21 CN disclosed
EP-3484859-B1 NEW DIFLUOROKETAMIDE DERIVATIVES AS HTRA1 INHIBITORS HOFFMANN LA ROCHE (CH) 2021-09-15 EP disclosed
EP-3538516-B1 PHENOXYTRIAZOLES HOFFMANN LA ROCHE (CH) 2021-06-16 EP disclosed
WO-2021108549-A1 NOVEL THYROMIMETICS AUTOBAHN THERAPEUTICS, INC. (US) 2021-06-03 WO disclosed
US-11020399-B2 Intermediates useful in the synthesis of compounds as modulators of protein kinases RHIZEN PHARMACEUTICALS SA (CH) 2021-06-01 US disclosed
CN-112679635-A Preparation method of supported metallocene catalyst and catalyst prepared by same 中国石油化工股份有限公司 2021-04-20 CN disclosed
US-20210101896-A1 MONOCYCLIC COMPOUNDS USEFUL AS GPR120 MODULATORS Valo Health, LLC 2021-04-08 US disclosed
US-20210053917-A1 NOVEL THYROMIMETICS AUTOBAHN THERAPEUTICS, INC. 2021-02-25 US disclosed
US-10865182-B2 Difluoroketamide derivatives as HtrA1 inhibitors HOFFMANN-LA ROCHE INC. (US) 2020-12-15 US disclosed
US-20200361849-A1 NOVEL THYROMIMETICS AUTOBAHN THERAPEUTICS, INC. 2020-11-19 US disclosed
EP-3197870-B1 INHIBITORS OF KRAS G12C MUTANT PROTEINS ARAXES PHARMA LLC (US) 2020-08-19 EP disclosed
US-10744117-B2 PPARG modulators for the treatment of osteoporosis THE SCRIPPS RESEARCH INSTITUTE (US) 2020-08-18 US disclosed
WO-2020118564-A1 NOVEL THYROMIMETICS AUTOBAHN THERAPEUTICS, INC. (US) 2020-06-18 WO disclosed
WO-2020123861-A1 NOVEL THYROMIMETICS AUTOBAHN THERAPEUTICS, INC. (US) 2020-06-18 WO disclosed
US-10442783-B2 2,3-disubstituted chromen-4-one compounds as modulators of protein kinases RHIZEN PHARMACEUTICALS SA (CH) 2019-10-15 US disclosed
US-20190282581-A1 NOVEL COMPOUNDS AS MODULATORS OF PROTEIN KINASES RHIZEN PHARMACEUTICALS AG (CH) 2019-09-19 US disclosed
EP-3538516-A1 PHENOXYTRIAZOLES F. Hoffmann-La Roche AG (CH) 2019-09-18 EP disclosed
US-20190262342-A1 COMBINATION THERAPIES FOR TREATMENT OF CANCER ARAXES PHARMA LLC 2019-08-29 US disclosed
US-10322130-B2 Substituted chromenones as modulators of protein kinases RHIZEN PHARMACEUTICALS SA (CH) 2019-06-18 US disclosed
EP-3009436-B1 KINASE INHIBITORS AND METHODS OF USE INTELLIKINE LLC (US) 2019-06-05 EP disclosed
US-20190152895-A1 NEW DIFLUOROKETAMIDE DERIVATIVES AS HTRAl INHIBITORS HOFFMANN-LA ROCHE INC. (US) 2019-05-23 US disclosed
EP-3484859-A1 NEW DIFLUOROKETAMIDE DERIVATIVES AS HTRA1 INHIBITORS H. Hoffnabb-La Roche Ag (CH) 2019-05-22 EP disclosed
US-20190105324-A9 SUBSTITUTED CHROMENONES AS MODULATORS OF PROTEIN KINASES RHIZEN PHARMACEUTICALS AG (CH) 2019-04-11 US disclosed
US-10220035-B2 Compounds as modulators of protein kinases RHIZEN PHARMACEUTICALS SA (CH) 2019-03-05 US disclosed
US-20180369196-A1 PPARG Modulators for the Treatment of Osteoporosis UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED 2018-12-27 US disclosed
EP-2198928-B1 Composition comprising a fatty substance and a silicate, dyeing process using it and devices therefore OREAL (FR) 2018-11-07 EP disclosed
US-10042258-B2 Composition for forming a resist upper-layer film and method for producing a semiconductor device using the composition NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2018-08-07 US disclosed
US-10016394-B2 PPARG modulators for treatment of osteoporosis THE SCRIPPS RESEARCH INSTITUTE (US) 2018-07-10 US disclosed
WO-2018087018-A1 PHENOXYTRIAZOLES F. HOFFMANN-LA ROCHE AG (CH) 2018-05-17 WO disclosed
US-20180110783-A1 NOVEL COMPOUNDS AS MODULATORS OF PROTEIN KINASES RHIZEN PHARMACEUTICALS SA (CH) 2018-04-26 US disclosed
US-20180110783-A1 NOVEL COMPOUNDS AS MODULATORS OF PROTEIN KINASES RHIZEN PHARMACEUTICALS SA (CH) 2018-04-26 US disclosed
WO-2018049324-A1 MONOCYCLIC COMPOUNDS USEFUL AS GPR120 MODULATORS NUMERATE, INC. (US) 2018-03-15 WO disclosed
WO-2018015240-A1 NEW DIFLUOROKETAMIDE DERIVATIVES AS HTRA1 INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2018-01-25 WO disclosed
US-20170362210-A1 ANTI-ESTROGENIC COMPOUNDS PFIZER INC. (US) 2017-12-21 US disclosed
US-9828378-B2 Kinase inhibitors and methods of use INTELLIKINE LLC (US) 2017-11-28 US disclosed
US-20170293227-A1 COATING LIQUID FOR RESIST PATTERN COATING NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2017-10-12 US disclosed
US-9775841-B2 Compounds as modulators of protein kinases RHIZEN PHARMACEUTICALS SA (CH) 2017-10-03 US disclosed
US-9775841-B2 Compounds as modulators of protein kinases RHIZEN PHARMACEUTICALS SA (CH) 2017-10-03 US disclosed
EP-2887144-B1 Toner and two-component developer CANON KK (JP) 2017-08-30 EP disclosed
US-9746768-B2 Resist overlayer film forming composition for lithography and method for producing semiconductor device using the same NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2017-08-29 US disclosed
US-20170205711-A1 COMPOSITION FOR FORMING A RESIST UPPER-LAYER FILM AND METHOD FOR PRODUCING A SEMICONDUCTOR DEVICE USING THE COMPOSITION NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2017-07-20 US disclosed
EP-2496567-B1 NOVEL BENZOPYRAN KINASE MODULATORS RHIZEN PHARMACEUTICALS S A (CH) 2017-07-12 EP disclosed
US-9665023-B2 Toner and two-component developer CANON KABUSHIKI KAISHA (JP) 2017-05-30 US disclosed
US-20170145003-A1 HETEROCYCLIC INHIBITORS OF THE SODIUM CHANNEL DeGiacomo, Mark G. (US) 2017-05-25 US disclosed
EP-3134391-A1 DIAMINOTRIAZINE COMPOUNDS AND THEIR USE AS HERBICIDES BASF SE (DE) 2017-03-01 EP disclosed
EP-2889691-B1 TONER AND TWO-COMPONENT DEVELOPER CANON KK (JP) 2017-03-01 EP disclosed
US-20170035730-A1 PPARG MODULATORS FOR TREATMENT OF OSTEOPOROSIS UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED 2017-02-09 US disclosed
US-9550775-B2 Substituted triazolopyridines and methods of use thereof GENENTECH, INC. (US) 2017-01-24 US disclosed
US-20160318890-A1 NOVEL KINASE MODULATORS RHIZEN PHARMACEUTICALS AG (CH) 2016-11-03 US disclosed
US-9421209-B2 Kinase modulators RHIZEN PHARMACEUTICALS SA (CH) 2016-08-23 US disclosed
US-9417540-B2 Toner and two-component developer CANON KABUSHIKI KAISHA (JP) 2016-08-16 US disclosed
EP-3050876-A2 KINASE MODULATORS Rhizen Pharmaceuticals S.A. (CH) 2016-08-03 EP disclosed
EP-3009436-A1 KINASE INHIBITORS AND METHODS OF USE Intellikine, LLC (US) 2016-04-20 EP disclosed
WO-2016049524-A1 INHIBITORS OF KRAS G12C MUTANT PROTEINS ARAXES PHARMA LLC (US) 2016-03-31 WO disclosed
US-20160024099-A1 KINASE INHIBITORS AND METHODS OF USE INTELLIKINE LLC 2016-01-28 US disclosed
EP-2968280-A1 SUBSTITUTED TRIAZOLOPYRIDINES AND METHODS OF USE THEREOF Genentech, Inc. (US) 2016-01-20 EP disclosed
US-20160009710-A1 SUBSTITUTED TRIAZOLOPYRIDINES AND METHODS OF USE THEREOF XENON PHARMACEUTICALS INC. (CA) 2016-01-14 US disclosed
US-20150320752-A1 NOVEL COMPOUNDS AS MODULATORS OF PROTEIN KINASES RHIZEN PHARMACEUTICALS AG (CH) 2015-11-12 US disclosed
EP-2313414-B1 KINASE INHIBITORS AND METHODS OF USE INTELLIKINE LLC (US) 2015-11-04 EP disclosed
WO-2015162166-A1 DIAMINOTRIAZINE COMPOUNDS AND THEIR USE AS HERBICIDES BASF SE (DE) 2015-10-29 WO disclosed
WO-2015161108-A1 PPARG MODULATORS FOR TREATMENT OF OSTEOPOROSIS THE SCRIPPS RESEARCH INSTITUTE (US) 2015-10-22 WO disclosed
US-9096611-B2 Kinase inhibitors and methods of use INTELLIKINE LLC (US) 2015-08-04 US disclosed
US-20150185650-A1 TONER AND TWO-COMPONENT DEVELOPER CANON KABUSHIKI KAISHA (JP) 2015-07-02 US disclosed
EP-2889691-A1 TONER AND TWO-COMPONENT DEVELOPER Canon Kabushiki Kaisha (JP) 2015-07-01 EP disclosed
US-20150174131-A1 NOVEL KINASE MODULATORS RHIZEN PHARMACEUTICALS AG (CH) 2015-06-25 US disclosed
US-20150177634-A1 TONER AND TWO-COMPONENT DEVELOPER CANON KABUSHIKI KAISHA (JP) 2015-06-25 US disclosed
EP-2887144-A1 Toner and two-component developer Canon Kabushiki Kaisha (JP) 2015-06-24 EP disclosed
CN-104725397-A Thienopyrimidine derivatives, a process for their preparation and pharmaceutical compositions containing them SERVIER LAB 2015-06-24 CN disclosed
US-9051265-B2 N-benzylindole modulators of PPARG THE SCRIPPS RESEARCH INSTITUTE (US) 2015-06-09 US disclosed
US-9018375-B2 Substituted chromenes as kinase modulators RHIZEN PHARMACEUTICALS SA (CH) 2015-04-28 US disclosed
WO-2014153037-A1 SUBSTITUTED TRIAZOLOPYRIDINES AND METHODS OF USE THEREOF GENENTECH, INC. (US) 2014-09-25 WO disclosed
US-20140080827-A1 NOVEL KINASE MODULATORS RHIZEN PHARMACEUTICALS SA (CH) 2014-03-20 US disclosed
CN-101822618-B Composition comprising a fatty substance and a silicate, dyeing or lightening process using it and devices therefore OREAL 2014-02-26 CN disclosed
US-8642607-B2 4H-chromen-4-one compounds as modulators of protein kinases RHIZEN PHARMACEUTICALS SA (CH) 2014-02-04 US disclosed
EP-1663979-B1 PHENYL OR PYRIDYL AMIDE COMPOUNDS AS PROSTAGLANDIN E2 ANTAGONISTS RAQUALIA PHARMA INC (JP) 2013-10-09 EP disclosed
CN-1867551-B Phenyl or pyridyl amide compounds as prostaglandin E2 antagonists RAQUALIA PHARMA INC 2013-09-11 CN disclosed
CN-101195599-B 2,4, 6-phenyl-substituted cyclic keto-enols BAYER CROPSCIENCE AG 2013-04-10 CN disclosed
EP-1802636-B1 PI3 KINASES INHIBITORS BOEHRINGER INGELHEIM INT (DE) 2013-03-27 EP disclosed
EP-1403723-B1 Toner CANON KK (JP) 2013-02-20 EP disclosed
US-8344180-B2 Hydrazine amide derivative SHIONOGI & CO., LTD. (JP) 2013-01-01 US disclosed
WO-2012170561-A1 N-BENZYLINDOLE MODULATORS OF PPARG THE SCRIPPS RESEARCH INSTITUTE (T.S.R.I.) (US) 2012-12-13 WO disclosed
WO-2012151525-A9 NOVEL COMPOUNDS AS MODULATORS OF PROTEIN KINASES RHIZEN PHARMACEUTICALS SA (CH) 2012-12-13 WO disclosed
US-20120309769-A1 N-BENZYLINDOLE MODULATORS OF PPARG SCRIPPS RESEARCH INSTITUTE, THE (US) 2012-12-06 US disclosed
US-20120289496-A1 NOVEL COMPOUNDS AS MODULATORS OF PROTEIN KINASES RHIZEN PHARMACEUTICALS SA (CH) 2012-11-15 US disclosed
US-20120289496-A1 NOVEL COMPOUNDS AS MODULATORS OF PROTEIN KINASES RHIZEN PHARMACEUTICALS SA (CH) 2012-11-15 US disclosed
WO-2012151525-A1 NOVEL COMPOUNDS AS MODULATORS OF PROTEIN KINASES RHIZEN PHARMACEUTICALS SA (CH) 2012-11-08 WO disclosed
CN-102516155-A 2,4, 6-phenyl-substituted cyclic keto-enols BAYER CROPSCIENCE AG 2012-06-27 CN disclosed
US-20120059001-A1 NOVEL KINASE MODULATORS INCOZEN THERAPEUTICS PVT. LTD. (IN) 2012-03-08 US disclosed
US-20120059001-A1 NOVEL KINASE MODULATORS INCOZEN THERAPEUTICS PVT. LTD. (IN) 2012-03-08 US disclosed
US-20120053165-A1 Novel Phenyl Imidazoles and Phenyl Triazoles As Gamma-Secretase Modulators PFIZER INC. (US) 2012-03-01 US disclosed
US-20120053165-A1 Novel Phenyl Imidazoles and Phenyl Triazoles As Gamma-Secretase Modulators PFIZER INC. (US) 2012-03-01 US disclosed
WO-2011120133-A1 NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS MERCK FROSST CANADA LTD. (CA) 2011-10-06 WO disclosed
US-20110172228-A1 KINASE INHIBITORS AND METHODS OF USE INTELLIKINE LLC 2011-07-14 US disclosed
EP-2343303-A1 PI3-kinase inhibitors Boehringer Ingelheim International GmbH (DE) 2011-07-13 EP disclosed
US-20110118257-A1 NOVEL KINASE MODULATORS RHIZEN PHARMACEUTICALS SA (CH) 2011-05-19 US disclosed
US-20110118257-A1 NOVEL KINASE MODULATORS RHIZEN PHARMACEUTICALS SA (CH) 2011-05-19 US disclosed
WO-2011055215-A2 NOVEL KINASE MODULATORS INCOZEN THERAPEUTICS PVT. LTD. (IN) 2011-05-12 WO disclosed
EP-1606254-B1 2,4,6-PHENYL SUBSTITUTED CYCLIC KETOENOLS BAYER CROPSCIENCE AG (DE) 2011-05-11 EP disclosed
US-7939231-B2 Magnetic toner CANON KABUSHIKI KAISHA (JP) 2011-05-10 US disclosed
EP-2313414-A2 KINASE INHIBITORS AND METHODS OF USE Intellikine, Inc. (US) 2011-04-27 EP disclosed
US-20110092368-A1 2,4,6-Phenyl-substituted cyclic ketoenols FISCHER REINER 2011-04-21 US disclosed
US-7888285-B2 2,4,6-phenyl substituted cyclic ketoenols BAYER CROPSCIENCE AG (DE) 2011-02-15 US disclosed
US-7879113-B2 fatty substance selected from fatty alcohol, fatty ester, animal, mineral or vegetable oil; silicate chosen from smectite, vermiculite, stevensite and chlorite clays; oxidation dyes or direct dyes; basifying agent (NaHCO3 or Na2CO3); and an oxidizing agent (H2O2); hair dye L'OREAL S.A. (FR) 2011-02-01 US disclosed
CN-101147100-B Magnetic toner CANON KK 2010-09-29 CN disclosed
WO-2010100606-A1 NOVEL PHENYL IMIDAZOLES AND PHENYL TRIAZOLES AS GAMMA-SECRETASE MODULATORS PFIZER INC. (US) 2010-09-10 WO disclosed
CN-101822618-A Composition comprising a fatty substance and a silicate, dyeing or lightening process using it and devices therefore OREAL 2010-09-08 CN disclosed
US-20100175202-A1 COMPOSITION COMPRISING AT LEAST ONE FATTY SUBSTANCE AND AT LEAST ONE SILICATE, DYEING OR LIGHTENING PROCESS USING IT AND DEVICES OR KITS THEREFOR L'OREAL S.A. (FR) 2010-07-15 US disclosed
EP-2198928-A2 Composition comprising a fatty substance and a silicate, dyeing or lightening process using it and devices therefore L'OREAL (FR) 2010-06-23 EP disclosed
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 US disclosed
WO-2010006086-A2 KINASE INHIBITORS AND METHODS OF USE INTELLIKINE, INC. (US) 2010-01-14 WO disclosed
US-20100004295-A1 Hydrazine amide derivative SHIONOGI & CO., LTD. 2010-01-07 US disclosed
US-7638250-B2 Toner, developing device, image forming apparatus, and image forming method using the toner RICOH COMPANY LIMITED (JP) 2009-12-29 US disclosed
EP-1875312-B1 MAGNETIC TONER CANON KK (JP) 2009-12-02 EP disclosed
EP-1339684-B1 MCH ANTAGONISTS AND THEIR USE IN THE TREATMENT OF OBESITY SCHERING CORP (US) 2009-11-04 EP disclosed
WO-2009132087-A1 THIOPHENE DERIVATIVES USEFUL AS OCULAR HYPOTENSIVE AGENTS ALLERGAN, INC. (US) 2009-10-29 WO disclosed
CN-100524048-C Toner CANON KK (JP) 2009-08-05 CN disclosed
US-20090035679-A1 MAGNETIC TONER CANON KABUSHIKI KAISHA (JP) 2009-02-05 US disclosed
US-7422832-B2 Magnetic toner CANON KABUSHIKI KAISHA (JP) 2008-09-09 US disclosed
CN-101195599-A 2,4, 6-phenyl-substituted cyclic keto-enols BAYER CROPSCIENCE AG (DE) 2008-06-11 CN disclosed
EP-1914221-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-04-23 EP disclosed
CN-101147100-A Magnetic toner CANON KK (JP) 2008-03-19 CN disclosed
EP-1875312-A1 MAGNETIC TONER Canon Kabushiki Kaisha (JP) 2008-01-09 EP disclosed
US-20070218389-A1 TONER, DEVELOPING DEVICE, IMAGE FORMING APPARATUS, AND IMAGE FORMING METHOD USING THE TONER RICOH COMPANY LIMITED (JP) 2007-09-20 US disclosed
CN-101038454-A Toner, developing device, image forming apparatus, and image forming method using the toner RICOH KK (JP) 2007-09-19 CN disclosed
US-7267919-B2 Particles of a polyester resin binder insoluble to tetrahydrofuran, a wax, and a colorant; excellent fixing property and high temperature offset characteristic CANON KABUSHIKI KAISHA (JP) 2007-09-11 US disclosed
US-20070202424-A1 MAGNETIC TONER CANON KABUSHIKI KAISHA (JP) 2007-08-30 US disclosed
US-7238714-B2 Aryl or heteroaryl amide compounds PFIZER JAPAN, INC. (JP) 2007-07-03 US disclosed
US-7232912-B2 Indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation AGOURON PHARMACEUTICALS, INC. (US) 2007-06-19 US disclosed
US-7232912-B2 Indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation AGOURON PHARMACEUTICALS, INC. (US) 2007-06-19 US disclosed
US-20070015664-A1 2,4,6-Phenyl substituted cyclic ketoenols BAYER CROPSCIENCE AG (DE) 2007-01-18 US disclosed
CN-1867551-A Phenyl or pyridyl amide compounds as prostaglandin E2 antagonists PFIZER (US) 2006-11-22 CN disclosed
WO-2006114900-A1 MAGNETIC TONER CANON KABUSHIKI KAISHA (JP) 2006-11-02 WO disclosed
US-7097951-B2 particles of a binder of polyester resin, a wax, and a colorant;a tetrahydrofuran soluble component, a powder of silica which becomes charged to a same polarity as the toner, a fine particle aggregate of silicone oil or silicone varnish, a resin fine particle and a metal oxide CANON KABUSHIKI KAISHA (JP) 2006-08-29 US disclosed
US-20060177753-A1 Toner CANON KABUSHIKI KAISHA (JP) 2006-08-10 US disclosed
CN-1787994-A 2,4, 6-phenyl-substituted cyclic keto-enols BAYER CROPSCIENCE AG (DE) 2006-06-14 CN disclosed
EP-1663979-A1 PHENYL OR PYRIDYL AMIDE COMPOUNDS AS PROSTAGLANDIN E2 ANTAGONISTS PFIZER INC. (US) 2006-06-07 EP disclosed
EP-1503249-B1 Magnetic toner CANON KK (JP) 2006-05-31 EP disclosed
US-7001703-B2 Toner CANON KABUSHIKI KAISHA (JP) 2006-02-21 US disclosed
US-20060035163-A1 Toner MORIBE SYUHEI 2006-02-16 US disclosed
EP-1606254-A1 2,4,6-PHENYL SUBSTITUTED CYCLIC KETOENOLS Bayer CropScience AG (DE) 2005-12-21 EP disclosed
US-20050065188-A1 Aryl or heteroaryl amide compounds ASKAT INC. (JP) 2005-03-24 US disclosed
WO-2005021508-A1 PHENYL OR PYRIDYL AMIDE COMPOUNDS AS PROSTAGLANDIN E2 ANTAGONISTS PFIZER INC. (US) 2005-03-10 WO disclosed
CN-1577123-A Magnetic toner CANON KK (JP) 2005-02-09 CN disclosed
US-20050026060-A1 Magnetic toner CANON KABUSHIKI KAISHA (JP) 2005-02-03 US disclosed
EP-1503249-A1 Magnetic toner CANON KABUSHIKI KAISHA (JP) 2005-02-02 EP disclosed
US-6828466-B2 Reacting arene with borane; oxidation, hydrogenation phenylboronic acid BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY 2004-12-07 US disclosed
US-6818370-B2 A COLORANT AND A BINDER RESIN COMPOSED OF TWO DIFFERENT RESINS (A) AND (B), WHEREIN (A) IS FREE OF TETRAHYDROFURAN INSOLUBLES, IS SELECTED FROM POLYESTER AND POLYOL RESINS AND (B) CONTAINS PROPOXYLATED BISPHENOL A AS POLYOL RICOH COMPANY, LTD. (JP) 2004-11-16 US disclosed
WO-2004080962-A1 2,4,6-PHENYL SUBSTITUTED CYCLIC KETOENOLS BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2004-09-23 WO disclosed
CN-1497364-A Toner ������������ʽ���� 2004-05-19 CN disclosed
US-20040081905-A1 Toner CANON KABUSHIKI KAISHA (JP) 2004-04-29 US disclosed
EP-1403723-A2 Toner CANON KABUSHIKI KAISHA (JP) 2004-03-31 EP disclosed
US-20040030197-A1 Process for the synthesis of phenols from arenes BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY 2004-02-12 US disclosed
US-20030162115-A1 Toner for developing electrostatic latent image, toner cartridge containing the toner and image forming apparatus RICOH COMPANY, LTD. (JP) 2003-08-28 US disclosed
US-6531496-B1 Pesticides in crop protection BAYER AKTIENGESELLSCHAFT (DE) 2003-03-11 US disclosed
CN-1347412-A aryloxy dithiazole dioxides BAYER AG (DE) 2002-05-01 CN disclosed
EP-1173428-A1 O-ARYL DITHIAZOLE DIOXIDES Bayer Aktiengesellschaft (DE) 2002-01-23 EP disclosed
WO-2000064881-A1 O-ARYL DITHIAZOLE DIOXIDES BAYER AKTIENGESELLSCHAFT (DE) 2000-11-02 WO disclosed
EP-0524027-B1 Polyester resin and its use as a toner binder SANYO CHEMICAL IND LTD (JP) 2000-01-12 EP disclosed
US-5747210-A COLORS AND POLYETHER BINDERS RICOH COMPANY, LTD. (JP) 1998-05-05 US disclosed
US-5302688-A Selected block phenolic oligomers and their use in phenolic resin compositions and in radiation-sensitive resist compositions OCG MICROELECTRONIC MATERIALS, INC. (US) 1994-04-12 US disclosed
US-5294682-A From dicarboxylic acid and oxyalkylated phenolic resin, low temperature fixing, offset resistance SANYO CHEMICAL INDUSTRIES, LTD. (JP) 1994-03-15 US disclosed
US-5235022-A Radiation sensitive; positive-working photoresists OCG MICROELECTRONIC MATERIALS, INC. (US) 1993-08-10 US disclosed
US-5234795-A Blocked novolak copolymer OCG MICROELECTRONIC MATERIALS, INC. (US) 1993-08-10 US disclosed
US-5232819-A Coating a substrate with a mixture of a radiation sensitive O-quinonediazide and a phenolic resin binder, imagewise exposure to radiation and developing to form a positive pattern in the coating OCG MICROELECTRONIC MATERIALS, INC. (US) 1993-08-03 US disclosed
US-5196289-A With o-quinonediazide OCG MICROELECTRONIC MATERIALS, INC. (US) 1993-03-23 US disclosed
US-5188921-A Mixture of o-quinonediazide compound and phenolic resin OCG MICROELECTRONIC MATERIALS, INC. (US) 1993-02-23 US disclosed
EP-0524027-A2 Polyester resin and its use as a toner binder SANYO CHEMICAL INDUSTRIES, LTD. (JP) 1993-01-20 EP disclosed
EP-0299890-B1 PROCESS FOR THE CHLORINATION OF PHENOLIC COMPOUNDS RHONE-POULENC CHIMIE (FR) 1991-12-11 EP disclosed
EP-0283411-B1 PROCESS FOR CHLORINATING PHENOLIC COMPOUNDS RHONE-POULENC CHIMIE (FR) 1991-08-07 EP disclosed
WO-1991004512-A1 SELECTED BLOCK COPOLYMER NOVOLAK BINDER RESINS AND THEIR USE IN RADIATION-SENSITIVE COMPOSITIONS OCG MICROELECTRONIC MATERIALS, INC. (US) 1991-04-04 WO disclosed
WO-1991003448-A1 SELECTED BLOCK PHENOLIC OLIGOMERS AND THEIR USE IN PHENOLIC RESIN COMPOSITIONS AND IN RADIATION-SENSITIVE RESIST COMPOSITIONS OCG MICROELECTRONIC MATERIALS, INC. (US) 1991-03-21 WO disclosed
EP-0255452-B1 PROCESS FOR CHLORINATING PHENOLIC COMPOUNDS RHONE-POULENC CHIMIE (FR) 1990-01-24 EP disclosed
EP-0299890-A1 Process for the chlorination of phenolic compounds RHONE-POULENC CHIMIE (FR) 1989-01-18 EP disclosed
EP-0283411-A1 Process for chlorinating phenolic compounds RHONE-POULENC CHIMIE (FR) 1988-09-21 EP disclosed
EP-0118377-B1 PROCESS FOR THE PRODUCTION OF METACHLORINATED PHENOLS RHONE-POULENC CHIMIE (FR) 1988-03-09 EP disclosed
EP-0255452-A1 Process for chlorinating phenolic compounds RHONE-POULENC CHIMIE (FR) 1988-02-03 EP disclosed
US-4540834-A HYDRODECHLORINATION OF POLYCHLOROPHENOL, HYDRIOTIC ACID RHONE-POULENC SPECIALITES CHIMIQUES (FR) 1985-09-10 US disclosed
EP-0118377-A2 Process for the production of metachlorinated phenols RHONE-POULENC CHIMIE (FR) 1984-09-12 EP disclosed
US-4469900-A PREFERENTIAL COMPLEXING WITH CALCIUM BROMIDE KOPPERS COMPANY, INC. (US) 1984-09-04 US disclosed
EP-0055196-B1 PROCESS FOR THE SYNTHESIS OF METACHLOROPHENOLS RHONE-POULENC SPECIALITES CHIMIQUES (FR) 1984-04-18 EP disclosed
EP-0055198-B1 PROCESS FOR THE SYNTHESIS OF METACHLOROPHENOLS RHONE-POULENC SPECIALITES CHIMIQUES (FR) 1984-04-04 EP disclosed
EP-0055197-B1 PROCESS FOR THE SYNTHESIS OF METACHLOROPHENOLS RHONE-POULENC SPECIALITES CHIMIQUES (FR) 1984-04-04 EP disclosed
US-4429168-A PREFERENTIAL COMPLEXING WITH A METAL HALIDE SALT KOPPERS COMPANY, INC. (US) 1984-01-31 US disclosed
US-4410738-A Preparation of meta-chlorophenols by selective hydrodechlorination of polychlorophenols RHONE-POULENC INDUSTRIES (FR) 1983-10-18 US disclosed
US-4410737-A Preparation of meta-chlorophenols by selective hydrodechlorination of polychlorophenols RHONE-POULENC INDUSTRIES (FR) 1983-10-18 US disclosed
US-4410739-A LEWIS ACID, NOBLE METAL CATALYST RHONE-POULENC INDUSTRIES (FR) 1983-10-18 US disclosed
EP-0055198-A1 Process for the synthesis of metachlorophenols RHONE-POULENC SPECIALITES CHIMIQUES (FR) 1982-06-30 EP disclosed
EP-0055198-A1 Process for the synthesis of metachlorophenols RHONE-POULENC SPECIALITES CHIMIQUES (FR) 1982-06-30 EP disclosed
EP-0055197-A1 Process for the synthesis of metachlorophenols RHONE-POULENC SPECIALITES CHIMIQUES (FR) 1982-06-30 EP disclosed
EP-0055196-A1 Process for the synthesis of metachlorophenols RHONE-POULENC SPECIALITES CHIMIQUES (FR) 1982-06-30 EP disclosed